Quantum Cyber Appoints President for Drone Subsidiary, Adds Independent Director
QUCY has more than doubled off its 52-week low of $0.3 on light trading volume (0.1× avg).
Summary
Quantum Cyber N.V. has appointed a President for its Quantum Drones subsidiary, a key step in its business pivot, and added an independent director to its board, enhancing governance.
Key Events · Executive and Board Changes · QUCY
-
New President for Quantum Drones Subsidiary
Peter O'Rourke has been appointed President of Quantum Drones Corporation, a wholly-owned subsidiary, effective July 1, 2026, to lead the company's new cyber/drones business.
-
Significant Stock Option Grant
Mr. O'Rourke will receive stock options to purchase 112,859 ordinary shares at an exercise price of $1.45 per share, representing a notable equity incentive for the new executive.
-
Independent Director Appointed
Louis Buffalino has been appointed as an independent director to the Board, filling a vacancy and joining the Audit, Compensation, and Nominating and Corporate Governance Committees.
Analysis · QUCY · Life Sciences
Quantum Cyber N.V. is executing its strategic pivot to cyber/drones by appointing Peter O'Rourke as President of its Quantum Drones subsidiary. This key executive hire, coupled with a significant stock option grant, signals a commitment to building out the new business. The addition of Louis Buffalino as an independent director further strengthens corporate governance during this transitional period.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 29.9% of the 1678 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.25%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, QUCY was trading at $1.40 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $32.8M. The 52-week trading range was $0.30 to $4.93. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.